Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SnapMD Brings Virtual Cardiologist To Patients

Executive Summary

Telehealth is a growing trend in cardiology and SnapMD says it's on the forefront.

You may also be interested in...



Market Intel: Digital Tech At The Heart Of Cardiology Innovation

Digital health technologies from smartphone applications, wearables, digital weight scales and telehealth are rapidly changing the landscape of cardiac care, offering new tools for engaging cardiology patients and enhancing cardiologists' workflows. There is a lot of hype, but also some real promise. Here's a look at what's happening and some expert insights on the benefits and challenges these new innovations represent, as well as market projections. Digital health was a major topic of discussion by cardiologists and entrepreneurs during this year's Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. This is the second in a series of articles on the future of cardiovascular technology, spotlighting discussion and presentations from TCT.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel